Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 16, 2022; 10(35): 13115-13121
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13115
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13115
Figure 3 Fundus photography, autofluorescence and optical coherence tomography during the patient’s follow-up.
A and B: Two weeks after systemic methotrexate and prednisolone combined with intravitreal methotrexate, the lesions in the right eye were almost transparent and optical coherence tomography showed no further progression; C: A new creamy-white lesion appeared at six o’clock at the equator of the left eye; D-F: Another two weeks later, no progression was noted in the right eye; G and H: The lesion in the left eye also started to turn transparent without any modification of systemic therapy, but was still hyperfluorescent on autofluorescence; I-M: At the last visit, no new lesions or enlargement of the scars was noted in both eyes.
- Citation: Luo L, Chen WB, Zhao MW, Miao H. Systemic combined with intravitreal methotrexate for relentless placoid chorioretinitis: A case report. World J Clin Cases 2022; 10(35): 13115-13121
- URL: https://www.wjgnet.com/2307-8960/full/v10/i35/13115.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i35.13115